Thursday, July 30, 2020 1:40:03 PM
They're probably under a ton of pressure since their sales are declining and their shareholders are probably pissed and want their management to change things up. The complete opposite over here :)
Insane Psychemedics had to cancel their streak of 94 consecutive dividend payments so their shareholders aren't too happy with that either.
But it makes sense strategically to combine the "alternative" testing approaches to saliva/blood/urine under one company for better sales coverage. I think financial engineering-wise it also makes sense since $PCHM is undervalued largely because it's an unknown OTC so if you put Psychemedics's earnings multiple on $PCHM, $PCHM looks drastically undervalued in comparison.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM